Advertisement

Topics

Bracco Diagnostics Inc. Company Profile

11:55 EDT 25th June 2018 | BioPortfolio

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs.


News Articles [372 Associated News Articles listed on BioPortfolio]

Shanghai Pharma Extends Research Collaboration with Bracco Imaging

Shanghai Pharma has signed a new 20-year collaboration with Milan's Bracco Imaging to develop Bracco's microbubbles technology as an ultrasound contrast agent to image tumor angiogenesis. Microbubbles...

Bracco Imaging refuerza su cartera de oncología intervencionista

MILÁN, 4 de marzo de 2018 /PRNewswire/ -- Bracco Imaging S.p.A., líder mundial en dispositivos de diagnóstico por imagen, ha anunciado hoy una colaboración estratégica con Read more...

Bracco Imaging verstärkt sein Portfolio bei interventioneller Onkologie

MAILAND, 3. März 2018 /PRNewswire/ -- Bracco Imaging S.p.A., ein weltweit führendes Unternehmen bei diagnostischer Bildgebung, gab heute eine strategische Partnerschaft mit R.A.W. S.r.l. bekannt, ...

Bracco Imaging reinforces its portfolio in Interventional Oncology

MILAN, March 3, 2018/PRNewswire/ -- Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced today a strategic partnership with R.A.W. S.r.l. - an Read more...

Bracco Imaging partners with R.A.W to expand interventional oncology portfolio

Bracco Imaging has partnered with Italian company R.A.W. to expand its portfolio of solutions for interventional oncology.

Bracco files patent infringement complaint against Jubilant for rubidium-82 generators

Bracco files patent infringement complaint against Jubilant for rubidium-82 generators moconnor Mon, 04/09/2018 - 17:20 Teaser Media

Week in Review: Grail, an Oncology Diagnostics Company, Taps China Investors for $300 Million

Deals and Financings  Grail, a Hong Kong-US diagnostics spinout from Illumina, announced a $300 million C financing led by China investors, bringing its VC total to $1.5 billion; Shanghai Pharma...

Emosis, 5─Diagnostics ink exclusive distribution deal for Emo─test, HIT Confirm, in CE Mark─regulated countries

Emosis, a medical device company specialising in cytomolecular diagnostics of hemostasis disorders, and 5─Diagnostics (5─D), a worldwide distributor for haemostasis products and in─vitro diagnos...

Drugs and Medications [26 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [195 Associated PubMed Articles listed on BioPortfolio]

Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.

The importance of medical imaging in the diagnosis and monitoring of cancer cannot be overstated. As personalized cancer treatments are gaining popularity, a need for more advanced imaging techniques ...

A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis.

To assess a new and highly specific, but low-cost, easily performed and suitable for large-scale applications method for renal fibrosis (RF) diagnostics.

Nucleic acid diagnostic approaches in parasitology.

Nucleic acid diagnostic technologies are partly replacing traditional microscopy and antigen detection methods in parasitological diagnostics. In particular, the diagnostics of parasitic diarrhea is u...

Is bronchoscopy always justified in diagnosis of haemoptysis?

Fiber-optic bronchoscopy (FOB) is commonly performed in the first line in diagnostic process of haemoptysis. However, lots of evidences suggest that in haemoptysis FOB do not always provide additional...

Molecular allergy diagnostics refines characterization of children sensitized to dog dander.

Sensitization to dog dander is an important risk factor for rhino-conjunctivitis and asthma, but not sufficient for diagnosing dog allergy. Molecular allergy diagnostics offers new opportunities for r...

Clinical Trials [199 Associated Clinical Trials listed on BioPortfolio]

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Companies [924 Associated Companies listed on BioPortfolio]

Bracco Diagnostics Inc.

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging dev...

Bracco Diagnostic Inc.

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging dev...

Bracco Imaging S.p.A.

Bracco Imaging S.p.A. is one of the World’s leading companies in the diagnostic imaging business. Bracco Imaging develops, manufactures and markets diagnostic imaging agents ...

Bracco Diagnostics Inc

Bracco, founded in 1927 by the family who gave it its name and which has been at its helm for three generations and still runs it today, is an integrated Healthcare Group, world leader in global solut...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

More Information about "Bracco Diagnostics Inc." on BioPortfolio

We have published hundreds of Bracco Diagnostics Inc. news stories on BioPortfolio along with dozens of Bracco Diagnostics Inc. Clinical Trials and PubMed Articles about Bracco Diagnostics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bracco Diagnostics Inc. Companies in our database. You can also find out about relevant Bracco Diagnostics Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record